0001209191-17-039021.txt : 20170609
0001209191-17-039021.hdr.sgml : 20170609
20170609211107
ACCESSION NUMBER: 0001209191-17-039021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170607
FILED AS OF DATE: 20170609
DATE AS OF CHANGE: 20170609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kite Pharma, Inc.
CENTRAL INDEX KEY: 0001510580
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 2225 COLORADO AVENUE
CITY: SANTA MONICA
STATE: CA
ZIP: 90404
BUSINESS PHONE: (310) 824-9999
MAIL ADDRESS:
STREET 1: 2225 COLORADO AVENUE
CITY: SANTA MONICA
STATE: CA
ZIP: 90404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOUMANI ROY
CENTRAL INDEX KEY: 0001230232
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36508
FILM NUMBER: 17904229
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-07
0
0001510580
Kite Pharma, Inc.
KITE
0001230232
DOUMANI ROY
C/O KITE PHARMA, INC.
2225 SANTA MONICA AVENUE
SANTA MONICA
CA
90404
1
0
0
0
Common Stock
2017-06-07
4
S
0
10000
84.4621
D
155017
D
Common Stock
2017-06-08
4
S
0
5000
84.5268
D
150017
D
Common Stock
25065
I
By spouse
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.265 to $85.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
/s/ David M. Tanen, Attorney-in-Fact
2017-06-09